Holen Sie sich die Stockscreener-App
12.32
2.99%
-0.38
Schlusskurs vom Vortag:
$12.70
Offen:
$12.58
24-Stunden-Volumen:
181.32K
Relative Volume:
2.05
Marktkapitalisierung:
$159.05M
Einnahmen:
$14.48M
Nettoeinkommen (Verlust:
$-26.11M
KGV:
-5.4535
EPS:
-2.2591
Netto-Cashflow:
$-23.86M
1W Leistung:
+0.82%
1M Leistung:
-8.06%
6M Leistung:
-28.99%
1J Leistung:
-37.43%
1-Tages-Spanne:
$12.19
$12.89
1-Wochen-Bereich:
$11.84
$12.76
52-Wochen-Spanne:
$11.84
$20.03
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
12.32 | 159.05M | 14.48M | -26.11M | -23.86M | -2.2591 |
VRTX
Vertex Pharmaceuticals Inc
|
513.22 | 130.08B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
241.80 | 96.53B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
802.76 | 82.65B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
875.22 | 55.04B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
383.66 | 43.40B | 5.76B | 514.49M | 1.10B | 4.4813 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-02 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Avoiding Lag: Real-Time Signals in (MDWD) Movement - Stock Traders Daily
Mediwound Ltd Ord Sh (MDWD-Q) Stock Price and News - The Globe and Mail
Weekly Recap: DoD funding for NexoBrid and VALUE Phase III reassessment - TradingView
TD Cowen reiterates MediWound stock rating ahead of trial data By Investing.com - Investing.com Canada
TD Cowen reiterates MediWound stock rating ahead of trial data By Investing.com - Investing.com Australia
TD Cowen reiterates MediWound stock rating ahead of trial data - Investing.com
MediWound Ltd. (MDWD) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediWound Ltd. Receives Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid - marketscreener.com
MDWD Looks 11.4% Overvalued on GF Value™ - GuruFocus
Understanding the Setup: (MDWD) and Scalable Risk - Stock Traders Daily
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - benzinga.com
MediWound receives $3.3M from DoD for NexoBrid development By Investing.com - Investing.com Canada
MediWound receives $3.3M from DoD for NexoBrid development - Investing.com
MediWound receives $3.3M from DoD for NexoBrid development By Investing.com - Investing.com Nigeria
MediWound Awarded Additional $3.3 Million from U.S. - GlobeNewswire
MediWound Awarded Additional $3.3 Million from U.S. - GlobeNewswire
A $21.8M program is developing burn care that can stay at room temperature - Stock Titan
MediWound Awarded Additional $3.3 Million from U.S. - globenewswire.com
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid® - Yahoo Finance
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - TradingView
TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification - Yahoo Finance
Reviewers found no safety concerns in MediWound's wound trial. - stocktitan.net
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification - GlobeNewswire
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Director of MediWound (NASDAQ: MDWD) trades shares via spouse - stocktitan.net
An FDA-approved burn treatment company’s CEO will join a New York fireside chat. - stocktitan.net
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewswire
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Hungarian fund owns double-digit MediWound (MDWD) stake - stocktitan.net
MediWound (NASDAQ: MDWD) seller Hess plans $50K, 3,958-share sale - stocktitan.net
New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq - Benzinga
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.ca
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.com
MediWound (MDWD) Q2 2026 Earnings Call Transcript - The Globe and Mail
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateRevenue Per Share - vinanet.vn
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateEarnings Forecast Report - siam.in
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayNegative Surprise Momentum - dars.gov.et
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayProfit Growth Outlook - vinanet.vn
What is HC Wainwright's Forecast for MediWound Q3 Earnings? - MarketBeat
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayCost Structure Review - dars.gov.et
Weekly Recap: Reaffirmed 2026 guidance and EscharEx Phase III enrollment - TradingView
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
Mediwound Ltd (MDWD) Stock News Today - TradingKey
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - Moomoo
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mediwound Ltd-Aktie (MDWD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rubinstein Samuel | Director |
Sep 01 '26 |
Sale |
12.72 |
525 |
6,678 |
0 |
| Hess Shmuel | COO & Chief Commercial Officer |
Aug 27 '26 |
Sale |
12.92 |
3,958 |
51,149 |
0 |
| Shmulik Hess | Officer |
Aug 27 '26 |
Proposed Sale |
12.70 |
3,958 |
50,267 |
0 |
| Hess Shmuel | COO & Chief Commercial Officer |
Aug 26 '26 |
Sale |
13.00 |
1,865 |
24,245 |
0 |
| SHAMIR NACHUM | Director |
Jun 03 '26 |
Buy |
14.00 |
6,000 |
83,996 |
55,815 |
| Fox David Morton | Director |
Jun 01 '26 |
Buy |
14.11 |
3,537 |
49,901 |
22,283 |
| Rubinstein Samuel | Director |
May 29 '26 |
Buy |
14.33 |
150 |
2,150 |
2,993 |
| Hess Shmuel | Officer |
Dec 02 '25 |
Proposed Sale |
17.21 |
3,693 |
63,557 |
0 |
2.30%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):